calendar-IconJanuary 31, 2025

Basel, Switzerland

Novartis announces the company’s fourth quarter and 2024 full year financial results.

Webcast and presentation


Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Novartis in Society Integrated Report 2024

The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and describes how we create sustainable value for stakeholders and society.

English (PDF 5.0 MB)

Prof. Dr. Ulf Landmesser (center) at the Charité hospital in Berlin, Germany

Annual Report 2024 and US Securities & Exchange Commission Form 20-F 2024

These reports provide a comprehensive overview of Novartis, including our company structure, corporate governance, operating and financial results, and compensation practices. They are filed with the SIX Swiss Exchange in Switzerland and the Securities and Exchange Commission in the US.

Annual Report 2024 (PDF 3.5 MB) | Form 20-F 2024 (PDF 3.4 MB)